Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, January 10, 2023
Qosina, a global supplier of OEM single- use components to the medical and pharmaceutical industries, is pleased to announce a partnership with ILC Dover, a leader in the innovative design and production of solutions for biopharmaceutical, ...
read more
Wednesday, November 30, 2016
MilliporeSigma has entered into a set of agreements with Evotec AG, whereby Evotec AG will provide screening services for MilliporeSigma's collection of genetic reagents such as CRISPR and shRNA libraries. Combining access to these libraries with ...
read more
AbbVie and Calibr announced a collaboration to develop T-cell therapies aimed primarily at cancer, including solid tumors.
read more
Catalent held a ground breaking ceremony at its Bloomington, Indiana site to mark the start of construction on a $112 million drug product manufacturing facility.
read more
Friday, February 19, 2021
Headlands Research has acquired Artemis Institute for Clinical Research.
read more
Thursday, September 21, 2023
Immutep Limited, a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, announced the regulatory authorization of eftilagimod alpha manufactured at commercial 2,000L scale for use in clinical ...
read more
Monday, February 05, 2024
mAbxience announced an agreement with Biosidus in which mAbxience will be responsible for the manufacture of the active ingredient Agalsidase Beta, developed by Biosidus as a biosimilar of Fabrazyme.
read more
Tuesday, January 21, 2025
In response to the growing demand for skilled professionals in South Carolina's life sciences sector, The Ritedose Corporation has partnered with Newberry College to launch a new Pharmaceutical Manufacturing program, set to begin in the summer of ...
read more
I-Mab Biopharma and ABL Bio, jointly announced that two companies had entered into a partnering agreement for ABL Bio to in-license the global rights excluding Greater China to I-Mab's bispecific antibodies of undisclosed target with licensing ...
read more
Wednesday, March 13, 2019
Bal Seal Engineering has achieved USP Class VI compliance for its SP-191 and SP-23 seal materials. It has also achieved ISO 10993-5 compliance for its SP-191, SP-23, and UPC-15 materials.
read more
Phesi, a data-driven provider of premier integrated clinical development analytics products and services, today announced the appointment of Otis Johnson, PhD, MPA, as the company’s chief commercial officer. Dr. Johnson’s primary responsibility will ...
read more
Ligand Pharmaceuticals has entered into an agreement with venBio Partners which permits venBio’s portfolio companies to enter into a pre-agreed worldwide OmniAb platform license agreement.
read more
Microbiotica has entered into a multi-year strategic collaboration with Genentech to discover, develop and commercialize biomarkers, targets and medicines for inflammatory bowel disease.
read more
Thursday, August 08, 2024
WuXi Biologics and Medigene AG announced that they have entered into a three-year, multi-target strategic partnership to design and co-research T cell receptor (TCR)-guided T Cell Engagers (TCR-TCEs) for the treatment of difficult-to-treat tumors.
read more
Wednesday, March 27, 2019
XenTech SAS announced a strategic collaboration with Gustave Roussy in Europe.
read more